Generics - Financial, Generics

Filter

Current filters:

FinancialGenerics

Popular Filters

1 to 25 of 199 results

Actavis’ fourth-qtr 2014 beats expectations

Actavis’ fourth-qtr 2014 beats expectations

18-02-2015

Ireland-headquartered generics major Actavis posted better-than-expected fourth-quarter and full-year…

AccountancyActavisAllerganFinancialForest LaboratoriesGenericsPharmaceuticalThomson ReutersUSA

Hospira fourth-qtr 2014 earnings beat expectations

Hospira fourth-qtr 2014 earnings beat expectations

12-02-2015

US drugmaker Hospira, a leading provider of injectable drugs and infusion technologies, and a global…

FinancialGenericsHospiraPfizerUnited States

Actavis to divest Doryx brand to Mayne Pharma for $50 million

Actavis to divest Doryx brand to Mayne Pharma for $50 million

10-02-2015

Ireland-headquartered generics major Actavis has entered an agreement with Mayne Pharma to divest the…

ActavisDermatologicalsDoryxFinancialGenericsLicensingMayne PharmaUSA

Cambrex to invest $45-$50 million in API capacity expansion; posts strong financials

06-02-2015

US drugmaker Cambrex has initiated the second significant expansion of its Charles City, Iowa, facility…

CambrexFinancialGenericsProduction

Teva 4th-quarter sales and earnings in line with expectations

05-02-2015

Israel-based Teva Pharmaceutical Industries today reported results for the quarter and the year ended…

FinancialGenericsPharmaceuticalPharmaceutical industryTeva Pharmaceutical IndustriesThomson ReutersUnited StatesVideo game development

With buy of Veropharm, Abbott to significantly increase revenue in Russia

With buy of Veropharm, Abbott to significantly increase revenue in Russia

17-12-2014

US drugmaker Abbott plans to significantly increase its revenue in the Russian market over the next several…

AbbottFinancialGenericsMarkets & MarketingProductionRussiaVeropharm

India revisits plans for free generic medicines, drug price fixing

India revisits plans for free generic medicines, drug price fixing

11-12-2014

Government hospitals in India that lack medicines, are overcrowded and understaffed, may soon be a thing…

FinancialGenericsHealthcareIndiaPharmaceuticalPoliticsPricing

Teva issues 2015 business outlook short of expectations

Teva issues 2015 business outlook short of expectations

11-12-2014

Israel-based generics giant Teva Pharmaceutical Industries saw its shares gain 1.17% to $57.05, despite…

CopaxoneFinancialGenericsIsraelPulmicortTeva Pharmaceutcal Industries

Good results from Stada Arz, despite challenging conditions

13-11-2014

German drugmaker Stada Arzneimittel has posted financial results for the first nine months of 2014, showing…

Eastern EuropeFinancialGenericsRussiaSTADA Arzneimittel

Actavis third-qtr sales rocket, but loss posted

Actavis third-qtr sales rocket, but loss posted

05-11-2014

Ireland-headquartered generics drug major Actavis today reported net revenue leapt 83% to $3.7 billion…

ActavisFinancialGenerics

New analysis of potential savings from Biosimilars in USA

New analysis of potential savings from Biosimilars in USA

04-11-2014

Introducing competing “biosimilar” versions of complex biologic drugs used to treat illnesses such…

Anti-Arthritics/RheumaticsBiosimilarsFinancialGenericsOncologyRegulationSandozUSA

Mylan third-qtr beats expectations

Mylan third-qtr beats expectations

31-10-2014

US generics drugmaker Mylan reported third-quarter 2014 financial results that beat analysts’ consensus…

FinancialGenericsMylan

Dr Reddy’s reports higher sales but downturn in pretax profit

Dr Reddy’s reports higher sales but downturn in pretax profit

29-10-2014

Indian generics drugmaker Dr Reddy’s Laboratories today reported its unaudited consolidated financial…

Dr Reddy's LaboratoriesFinancialGenerics

Valeant third-qtr profits beat expectations

20-10-2014

Canadian drugmaker Valeant Pharmaceuticals International has posted third-quarter 2014 financial results…

AllerganFinancialGenericsMergers & AcquisitionsValeant Pharmaceuticals International

Netherlands Pharma market growth held back by govt generics policy

14-10-2014

The Netherlands’ pharmaceutical market value will rise slowly from around $6.7 billion in 2014 to $7.2…

FinancialGenericsHealthcareMarkets & MarketingNetherlands

Indian pharma envisages exports expansion, including in Latin American

Indian pharma envisages exports expansion, including in Latin American

16-09-2014

India Brand Equity Foundation (IBEF) today announced the sustained collective efforts being made by the…

FinancialGenericsIndiaMarkets & MarketingPatentsSouth America

USA’s generic pharma savings reach highest-ever watermark

USA’s generic pharma savings reach highest-ever watermark

15-09-2014

The US Generic Pharmaceutical Association (GPhA) last week released a report showing that generic drugs…

BiosimilarsFinancialGenericsMarkets & MarketingUSA

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

Prosonix’ generic version of GSK’s Flixotide Evohaler under review in EU

02-09-2014

UK-based Prosonix, a speciality pharmaceutical company developing a portfolio of inhaled respiratory…

EuropeEvohalerFinancialFluticasone PropionateGenericsGlaxoSmithKlineMylanProsonixRegulationRespiratory and Pulmonary

Indian Pharma increasing capital and research spending

Indian Pharma increasing capital and research spending

28-08-2014

With over $50 billion worth of drugs set to go off patent over the next two years in the USA, Indian…

CiplaDr Reddy's LaboratoriesFinancialGenericsGlenmark PharmaceuticalsIndiaLupinMergers & AcquisitionsResearchSun Pharmaceuticals

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

EMS Group inaugurates NovaMed/EMS, Manaus' first pharmaceutical factory

27-08-2014

Brazilian Minister of Health Arthur Chioro participated in the inauguration ceremony of NovaMed/EMS,…

BrazilEMS GroupFinancialGenericsNovaMedProduction

Indian pharmaceutical sector to see strong growth, says Moody’s

Indian pharmaceutical sector to see strong growth, says Moody’s

25-08-2014

Moody's Investors Service says that India's pharmaceutical market will continue to grow in the double…

FinancialGenericsIndiaMarkets & MarketingMergers & Acquisitions

Hikma's profits boosted in first half by good injectables sales

Hikma's profits boosted in first half by good injectables sales

20-08-2014

Revenue for Jordanian drugmaker Hikma Pharmaceuticals in the first half of 2014 rose 16% following a…

FinancialGenericsHikma PharmaceuticalsJordan

PHARMAC tender for generic medicines contributes NZ$38 million savings

PHARMAC tender for generic medicines contributes NZ$38 million savings

18-08-2014

New Zealanders’ use of generic medicines is likely to grow further following the just-completed 2013/14…

Atypical antipsychoticsFinancialGenericsHealthcareNew Zealand

Despite difficult environment, Stada Arz posts solid results

Despite difficult environment, Stada Arz posts solid results

11-08-2014

German generic and branded drugmaker Stada Arzneimittel says that, in the first half of 2014, the group’s…

Business FinanceFinancialGenericsGermanyGermanySTADA Arzneimittel

1 to 25 of 199 results

Back to top